Radiation Dosimetry in Non-Hodgkin’s B-Cell Lymphoma Patients Treated with 131I-Rituximab Radioimmunotherapy

• Main Authors: Wirote Changmuang, Arpakorn Kositwattanarerk, Kittipong Thongklam, Kanokon Poonak, Putthiporn Charoenphun, Thanete Doungta, วิโรจน์ ช่างม่วง, อาภากร โฆษิตวัฒนฤกษ์, กิตติพงษ์ ทองกล่ำ, กนกอร ภู่นาค, พุทธิพรณ์ เจริญพันธุ์, ธเนศ ดวงตา
• Other Authors: Mahidol University. Faculty of Medicine Ramathibodi Hospital. Department of Diagnostic and Therapeutic Radiology
• Format: Original Article
• Language: English
• Published: 2022
• Subjects: I-131-Rituximab; Radioimmunotherapy; Non-Hodgkin’s Lymphoma; Red marrow dose; Absorbed dose
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/79576

Objective: The aim of this study was to calculate a therapeutic dose of 131I-Rituximab after a tracer patient-specific dosimetry based on whole body absorbed dose of 0.75 Gy. Methods: Eight patients (mean ± S.D. age, 59.0 ± 11.6 years) were given initial tracer activity of 131I-Rituximab intravenou...